{
    "code": "02022657",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022657",
    "time": "2023-10-26 19:26:27",
    "許可證字號": "衛署藥輸字第022657號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/10\/26",
    "發證\/登錄日期": "88\/10\/26",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202265703",
    "中文品名": "善得定長效緩釋注射劑２０毫克",
    "英文品名": "SANDOSTATIN LAR MICROSPHERES FOR INJECTION 20MG",
    "適應症": "肢端肥大症，功能性胃、腸、胰臟內分泌腫瘤。治療患有晚期間腸(midgut)或已排除原位非間腸處而原位不明之分化良好(well-differentiated)的神經內分泌瘤患者。",
    "劑型": "270注射劑",
    "包裝": "100小瓶以下盒裝 Bromobutyl rubber瓶塞之玻璃小瓶裝，附安全針頭與小瓶轉接頭(Vial adaptor)及溶劑(2ml prefilled syringe of Vehicle）玻璃小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "OCTREOTIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "SANDOZ GMBH,  SCHAFTENAU PLANT",
            "製造廠廠址": "BIOCHEMIESTRASSE 10, 6336 LANGKAMPFEN, AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": "半成品(BULK MICROSPHERE)"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "NOVARTIS PHARMA STEIN AG",
            "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "FINAL ASSEMBLY"
        },
        {
            "製造廠名稱": "Abbott Biologicals B.V.",
            "製造廠廠址": "VEERWEG 12, NL-8121 AA OLST, THE NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "2.5ml PREFILLED SYRINGE"
        },
        {
            "製造廠名稱": "ABBOTT BIOLOGICALS B.V.",
            "製造廠廠址": "VEERWEG 12, 8121 AA OLST, THE NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6828001300",
            "成分名稱": "OCTREOTIDE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "022657_Sandostatin lar microspheres for injection 20mg-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022657&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "3_仿單電子檔_Sandostatin LAR 20, 30mg_TWI-151021-110-10-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022657&Seq=030&Type=9"
        },
        {
            "title": "022657_Sandostatin LAR 20mg_FB-109-07-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022657&Seq=006&Type=8"
        },
        {
            "title": "Sandostatin LAR 20mg_FB-109-06-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022657&Seq=005&Type=8"
        },
        {
            "title": "Sandostatin LAR 20MG_2212289_TW_p2_FB_X-4-107-10-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022657&Seq=004&Type=8"
        },
        {
            "title": "Sandostatin LAR 20mg_20160408-107-02-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022657&Seq=003&Type=8"
        }
    ]
}